Alexanderson-Rosas E, Berríos-Bárcenas E, Meave A, de la Fuente-Mancera JC, Oropeza-Aguilar M, Barrero-Mier A, Monroy-González AG, Cruz-Mendoza R, Guinto-Nishimura GY. Novel contributions of multimodality imaging in hypertension: A narrative review. World J Hypertens 2015; 5(2): 28-40 [DOI: 10.5494/wjh.v5.i2.28]
Corresponding Author of This Article
Dr. Enrique Berríos-Bárcenas, MD, Cardiac Magnetic Resonance Department, National Institute of Cardiology Ignacio Chávez, uan Badiano #1. Colonia Sección XVI, Mexico City 14080, Mexico. berrios.md@gmail.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Hypertens. May 23, 2015; 5(2): 28-40 Published online May 23, 2015. doi: 10.5494/wjh.v5.i2.28
Novel contributions of multimodality imaging in hypertension: A narrative review
Erick Alexanderson-Rosas, Enrique Berríos-Bárcenas, Aloha Meave, Juan Carlos de la Fuente-Mancera, Mariano Oropeza-Aguilar, Alejandro Barrero-Mier, Andrea de Guadalupe Monroy-González, Raul Cruz-Mendoza, Gerardo Yoshiaki Guinto-Nishimura
Erick Alexanderson-Rosas, Juan Carlos de la Fuente-Mancera, Mariano Oropeza-Aguilar, Alejandro Barrero-Mier, Andrea de Guadalupe Monroy-González, Raul Cruz-Mendoza, Gerardo Yoshiaki Guinto Nishimura, Nuclear Cardiology Department, National Institute of Cardiology Ignacio Chávez, Mexico City 14080, Mexico
Enrique Berríos-Bárcenas, Aloha Meave, Cardiac Magnetic Resonance Department, National Institute of Cardiology Ignacio Chávez, Mexico City 14080, Mexico
Author contributions: Alexanderson-Rosas E and Meave A collaborated in making the final revision of the document; Berríos-Bárcenas E and de la Fuente-Mancera JC collaborated in the drafting of the document; Oropeza-Aguilar M, Barrero-Mier A and Monroy-González AG contributed with the analysis and acquisition of data; Cruz-Mendoza R and Guinto-Nishimura GY in making critical revision of the document.
Conflict-of-interest: The authors whose names are listed below certify that they have not received any fees as speakers, consultants or any other position, nor have they received any research funding from any organization and do not have any affiliations with any organization or entity with any financial interest. The authors whose names are listed below report no financial interest in the subject matter discussed in this manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Enrique Berríos-Bárcenas, MD, Cardiac Magnetic Resonance Department, National Institute of Cardiology Ignacio Chávez, uan Badiano #1. Colonia Sección XVI, Mexico City 14080, Mexico. berrios.md@gmail.com
Telephone: +52-55-54850672 Fax: +52-55-55732111
Received: September 29, 2014 Peer-review started: September 30, 2014 First decision: November 14, 2014 Revised: December 5, 2014 Accepted: March 4, 2015 Article in press: March 6, 2015 Published online: May 23, 2015 Processing time: 234 Days and 13.7 Hours
Abstract
Hypertension is currently one of the most prevalent illnesses worldwide, and is the second most common cause of heart failure, only behind ischemic cardiomyopathy. The development of novel multimodality imaging techniques in recent years has broadened the diagnostic methods, risk stratification and monitoring of treatment of cardiovascular diseases available for clinicians. Cardiovascular magnetic resonance (CMR) has a great capacity to evaluate cardiac dimensions and ventricular function, is extremely useful in ruling-out ischemic cardiomyopathy, the evaluation of the vascular system, in making the differential diagnosis for resistant hypertension and risk stratification for hypertensive cardiomyopathy and constitutes today, the method of choice to evaluate left ventricular systolic function. Computed tomography (CT) is the method of choice for the evaluation of vascular anatomy, including coronary arteries, and is also able to provide both functional and structural information. Finally, nuclear cardiology studies have been traditionally used to evaluate myocardial ischemia, along with offering the capacity to evaluate ventricular, endothelial and cardiac innervation function; information that is key in directing the treatment of the patient. In this narrative review, the most recent contributions of multimodality imaging to the patient with hypertension (CMR, CT and nuclear cardiology) will be reviewed.
Core tip: Diverse imaging modalities are playing a larger role every day in the diagnosis, treatment decisions and follow-up of patients. This is especially true in patients with hypertension. The merger of diverse imaging techniques has led to the rise of Multimodality Imaging, using tools such as cardiovascular magnetic resonance, computed tomography and nuclear cardiology that aid clinicians make the best therapeutic decisions. In this article, we will make a comprehensive review of the most novel contributions of multimodality imaging to patients with hypertension.
